DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Gabelli & Co. Downgrades Tetraphase Pharmaceutical to Hold

Gabelli & Co. analyst Kevin Kedra downgrades Tetraphase Pharmaceutical (NASDAQ:TTPH) from Buy to Hold.

Benzinga · 01/24/2020 12:23

Gabelli & Co. analyst Kevin Kedra downgrades Tetraphase Pharmaceutical (NASDAQ:TTPH) from Buy to Hold.